Biochemical and structural approaches define how the chaperone TAPBPR interacts with MR1 molecules, including empty and ligand-loaded MR1, and facilitates presentation of metabolite-derived antigen ligands by MR1 complexes.
- Andrew C. McShan
- Christine A. Devlin
- Nikolaos G. Sgourakis
